[HTML][HTML] Post-acute COVID-19 syndrome
A Nalbandian, K Sehgal, A Gupta, MV Madhavan… - Nature medicine, 2021 - nature.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
In December, 2019, reports emerged from Wuhan, China, of a severe acute respiratory
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). By the …
Persistent poor health after COVID-19 is not associated with respiratory complications or initial disease severity
L Townsend, J Dowds, K O'Brien, G Sheill… - Annals of the …, 2021 - atsjournals.org
Rationale: Much is known about the acute infective process of severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease …
syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease …
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
J Villar, C Ferrando, D Martínez, A Ambrós… - The Lancet …, 2020 - thelancet.com
Background There is no proven specific pharmacological treatment for patients with the
acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS …
acute respiratory distress syndrome (ARDS). The efficacy of corticosteroids in ARDS …
Pulmonary fibrosis secondary to COVID-19: a call to arms?
P Spagnolo, E Balestro, S Aliberti… - The Lancet …, 2020 - thelancet.com
As of May 6, 2020, nearly 3· 7 million people have been infected and around 260 000
people have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all …
people have died from coronavirus disease 2019 (COVID-19) worldwide. 1 Almost all …
Spectrum of fibrotic lung diseases
M Wijsenbeek, V Cottin - New England Journal of Medicine, 2020 - Mass Medical Soc
Pulmonary Fibrotic Diseases This review covers fibrotic pulmonary diseases. Although
idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases …
idiopathic pulmonary fibrosis is very common, the review focuses mainly on fibrotic diseases …
A review of persistent post-COVID syndrome (PPCS)
B Oronsky, C Larson, TC Hammond, A Oronsky… - Clinical reviews in …, 2023 - Springer
Persistent post-COVID syndrome, also referred to as long COVID, is a pathologic entity,
which involves persistent physical, medical, and cognitive sequelae following COVID-19 …
which involves persistent physical, medical, and cognitive sequelae following COVID-19 …
CT lung abnormalities after COVID-19 at 3 months and 1 year after hospital discharge
B Vijayakumar, J Tonkin, A Devaraj, KEJ Philip… - Radiology, 2022 - pubs.rsna.org
Background Data on the long-term pulmonary sequelae in COVID-19 are lacking. Purpose
To assess symptoms, functional impairment, and residual pulmonary abnormalities on serial …
To assess symptoms, functional impairment, and residual pulmonary abnormalities on serial …
Pathophysiology of Post-COVID syndromes: a new perspective
GES Batiha, HM Al-Kuraishy, AI Al-Gareeb, NN Welson - Virology Journal, 2022 - Springer
Most COVID-19 patients recovered with low mortality; however, some patients experienced
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …
long-term symptoms described as “long-COVID” or “Post-COVID syndrome”(PCS). Patients …